Skip to main content
logo
Candel Therapeutics, Inc. (CADL)
NASDAQ: CADL · Real-Time Price · USD
8.91
-0.03 (-0.34%)
At close: May 14, 2026, 4:00 PM EDT
8.94
+0.03 (0.34%)
After-hours: May 14, 2026, 4:52 PM EDT

Candel Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
----0.130.13
Gross Profit
----0.130.13
Selling, General & Admin
20.117.7714.0613.8914.0610.67
Research & Development
36.3230.519.3124.5120.7915.18
Total Operating Expenses
56.4248.2733.3738.3934.8525.85
Operating Income
-56.42-48.27-33.37-38.39-34.72-25.73
Interest Income
4.33.921.092.081.22-
Interest Expense
-3.38-2.12-2.09-2.6-1.71-
Other Non-Operating Income (Expense)
0.988.29-20.80.9716.42-10.4
Total Non-Operating Income (Expense)
210.08-21.810.4515.93-10.4
Pretax Income
-54.42-38.18-55.18-37.94-18.79-36.12
Net Income
-54.42-38.18-55.18-37.94-18.79-36.12
Net Income to Common
-54.42-38.18-55.18-37.94-18.79-36.12
Shares Outstanding (Basic)
565332292919
Shares Outstanding (Diluted)
565332292919
Shares Change (YoY)
46.92%67.19%9.47%0.39%52.72%62.48%
EPS (Basic)
-0.98-0.72-1.74-1.31-0.65-1.91
EPS (Diluted)
-0.98-0.72-1.74-1.31-0.65-1.91
Shares Outstanding
73.2654.946.8129.0928.9228.69
Free Cash Flow
-48.99-38.9-27.04-34.7-32.72-24.05
Free Cash Flow Per Share
-0.88-0.73-0.85-1.20-1.14-1.27
Gross Margin
----100.00%100.00%
Operating Margin
-----27777.60%-20580.80%
Profit Margin
-----15035.20%-28899.20%
FCF Margin
-----26172.80%-19242.40%
EBITDA
-55.67-47.42-32.38-37.43-33.94-25.49
EBITDA Margin
-----27155.20%-20395.20%
EBIT
-56.42-48.27-33.37-38.39-34.72-25.73
EBIT Margin
-----27777.60%-20580.80%
Updated May 14, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q